Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures
May 20, 2025 For further information, please contact: Joost Maltha Philips Global External Relations Tel.: +31 6 10 55 8116 E-Mail: joost.maltha@philips.com About Royal Philips Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and pro ...